Arsenal Medical Announces Complete Enrollment of the Initial Cohort in the EMBO-02 Study Assessing NeoCast™ for the Treatment of Chronic Subdural Hematoma
/
DateFeb 06 2025
WALTHAM, Mass. — Arsenal Medical, a clinical-stage company developing medical devices from innovative biomaterials, today announced the complete enrollment of an initial cohort of 10... Read More →